Hepatitis B by the numbers1
Even with a safe and effective vaccine, the numbers still paint a problematic picture. That’s where we want to help.
Even with a safe and effective vaccine, the numbers still paint a problematic picture. That’s where we want to help.
People born in countries with an HBV prevalence of ≥2%
People born in the United States not vaccinated as infants whose parents were born in regions with high rates of BV infection (HBsAg prevalence of ≥8%)
Men who have sex with men
People who inject drugs
People with HIV
Household and sexual contacts of HBV-infected people
People requiring immunosuppressive therapy
People with end-stage renal disease (including hemodialysis patients)
Blood and tissue donors
People with elevated alanine aminotransferase levels (>19 IU/L for women and >30 IU/L for men)
Pregnant women (hepatitis B surface antigen [HBsAg] only is recommended)
Infants born to HBV-infected mothers (HBsAg and antibody to hepatitis B surface antigen [anti-HBs] only are recommended)